HealthEquity Reports Second Quarter Ended July 31, 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
HealthEquity (HQY) Tops Q2 EPS by 10c, Offers FY Guidance
September 3, 2019 4:06 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $85.32 million.
GUIDANCE:
HealthEquity sees FY2020 revenue of $341-347 million, versus the consensus of $343.3 million.
We have updated the HealthEquity standalone outlook for the year ending January 31, 2020. We expect our revenue to be between $341 million and $347... More